deltatrials
Completed PHASE2/PHASE3 NCT00430105

Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides

Randomized Trial of Intravenous Pulse Versus Oral Continuous Cyclophosphamide for Induction of Remission in Systemic ANCA-Associated Vasculitides

Sponsor: Cambridge University Hospitals NHS Foundation Trust

Conditions ANCA Associated Systemic Vasculitis Microscopic Polyangiitis Wegener's Granulomatosis
Interventions cyclophosphamide
Updated 4 times since 2017 Last updated: Jan 31, 2007 Started: Feb 28, 1998 Completion: Apr 30, 2004

A PHASE2/PHASE3 clinical study on ANCA Associated Systemic Vasculitis and Microscopic Polyangiitis, this trial is completed. The trial is conducted by Cambridge University Hospitals NHS Foundation Trust and has accumulated 4 data snapshots since 1998. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  4. Jan 2017 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Feb 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cambridge University Hospitals NHS Foundation Trust
Data source: Cambridge University Hospitals NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.